Adva Network Security launches strategic project within European collaboration to create sovereign clouds
Adva Network Security announced today that it is launching a nationally funded project to develop cloud-optimized, secure network access technology. As part of the Important Projects of Common European Interest (IPCEI), a comprehensive funding initiative is underway to create scalable, real-time and open Next-Generation Cloud Infrastructure and Services (IPCEI-CIS) aimed at ensuring digital sovereignty. Among the 19 German companies participating, Adva Network Security is responsible for developing highly secure network access technology featuring an integrated edge cloud and software solution for robust operation. The solution will be an essential component of a European independent cloud platform, enabling the rapid processing of mission-critical and sensitive data at the network edge.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240320831952/en/
Funded by the European Union – NextGenerationEU (Graphic: Business Wire)
“The security of mission-critical networks poses major challenges for operators: Quantum computing threatens to compromise established security mechanisms, while the push for digitization requires fast and trusted data processing at the edge of networks. Our project within IPCEI-CIS addresses both of these problems and offers very simple operation through automation,” said Wolfgang Keil, senior director of cybersecurity project management at Adva Network Security. “Leveraging our experience in quantum security, protected hosting and the operation of high-security networks, we’re developing highly secure access to the European cloud. This includes protected hosting of virtualized network functions at the edge, enabling sensitive data to be processed safely and quickly on-site before being transferred securely to the cloud.”
The TRUsted cloud connectivity for automated Endpoint SECurity (TRUE-SEC) project was launched on January 1, 2024, and will run for three years. It is funded by the Federal Ministry for Economic Affairs and Climate Protection based on a resolution of the German Bundestag and financed by the European Union. Its mission is to create an innovative solution for secure network access. Renowned for its expertise in the high-security network domain, Adva Network Security has been entrusted with developing this critical component for an end-to-end European cloud infrastructure. In collaboration with many project partners, IPCEI-CIS aims to establish a standardized, open and sustainable cloud infrastructure that ensures future-proof security for data services that are compliant with stringent regulatory requirements. The initiative marks a crucial step in advancing autonomous and sovereign cloud technology across Europe.
“Already deployed across numerous high-security networks, our technology safeguards some of the most sensitive and mission-critical data. Yet, new threat scenarios require continuous improvement. Through our participation in the IPCEI-CIS initiative, we’re making an important contribution to the sovereignty of European cloud infrastructure and services,” commented Michael Roth, GM of Adva Network Security. “The funding will enable us to expand our competence center for network security in Berlin. Our growing team of cybersecurity and network specialists is playing a vital role in driving the security – and thereby the acceptance – of cloud services through innovative and technologically sophisticated solutions. We’re proud to be able to make this contribution and honored to help shape Germany’s digital future.”
About Adva Network Security
Adva Network Security has built a fierce reputation for protecting packet optical networks. We pioneered low-latency, multi-layer encryption solutions that are right now safeguarding data in motion for many mission-critical applications. Our ConnectGuard™ security technology is even combating tomorrow’s quantum security threats. Built by the industry’s leading security experts, our German-based organization helps organizations and government agencies security-harden their networks to ensure critical infrastructure is protected against cyber threats. Our development and manufacturing processes, as well as our security solutions, have been approved and certified by leading governmental security agencies. For more information on how we can help you, please visit www.advasecurity.com.
Published by
Adva Network Security GmbH, Berlin, Germany
www.advasecurity.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240320831952/en/
Contact information
For media
Ulrich Kohn
t +49 30 2636969166
info@advasecurity.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea24.4.2025 10:00:00 EEST | Press release
PCI Pharma Services (“PCI”) – a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies – is acquiring an entire equity stake in Ajinomoto Althea, Inc. (“Althea”), a US-based sterile fill-finish CDMO and 100% subsidiary of Japan-based Ajinomoto Co., Inc. Scheduled for completion in May 2025, the acquisition provides PCI with its first-ever North American manufacturing location for prefilled syringes and cartridges – including isolator technology for these formats – as well as high potent manufacturing suitable for antibody-drug conjugates (ADCs). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250424617540/en/ PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea. Althea’s robust clinical- and commercial-stage services for injectable drug products augments PCI’s deep industry experience, aligning with the company’s global sterile fill-fini
Wolters Kluwer Launches CCH iFirm Personal Tax and CCH iFirm Accounts Production for U.K. Tax and Accounting Professionals24.4.2025 10:00:00 EEST | Press release
Wolters Kluwer Tax and Accounting (TAA) today announced the launch of CCH iFirm Personal Tax and CCH iFirm Accounts Production within its award-winning cloud-based practice management and compliance software platform CCH iFirm® for U.K. professionals. These enhancements deliver seamless, integrated platforms that enhance efficiency, reduce errors, ensure compliance and a more efficient workflow for tax and accounting professionals. Bas Kniphorst, Executive Vice President and Managing Director, Wolters Kluwer TAA Europe said: “These cloud solution modules represent a significant milestone in our commitment to innovation and quality. By providing cutting-edge tools that meet the evolving demands of the tax and accounting industry, we are strengthening our position as a leader in cloud accounting solutions. This not only enhances our product portfolio but also drives growth and reinforces our dedication to delivering exceptional value to our clients. We are confident these launches will e
Jeffrey Lawrence Appointed Chairman of Joe & the Juice24.4.2025 10:00:00 EEST | Press release
Joe & the Juice (“the Company”), an urban juice bar and coffee concept selling freshly prepared juices, coffee, sandwiches and more, today announced that Jeffrey Lawrence, a member of the Company’s Board of Directors since April 2024, has been appointed as Chairman of the Board. Thomas Nørøxe, Chief Executive Officer of Joe & the Juice, said, “Jeff’s elevation to Chairman of Joe & the Juice reflects how his active participation has made a material difference to the Company’s performance and strategy. Over the past year, Joe & the Juice has achieved continued impressive same store sales and revenue growth as we also opened our 400th unit globally. Unit economics remain incredibly strong and digital sales are now nearing 40%. Jeff’s experience will be vital as we continue to expand globally through both company-owned and franchise openings.” Jeffrey Lawrence commented, “Joe & the Juice continues to represent one of the most exciting and dynamic restaurant brands, with true global consume
Manhattan Associates Wins Google Cloud Business Applications Partner of the Year Award for Supply Chain and Logistics24.4.2025 10:00:00 EEST | Press release
Manhattan Associates Inc. (NASDAQ: MANH) today announced that it has received the 2025 Google Cloud Business Applications Partner of the Year Award for Supply Chain and Logistics. This prestigious award highlights Manhattan’s role as an innovator within the Google Cloud ecosystem, its commitment to driving customer success, and its pioneering application of Agentic AI and Generative AI (GenAI) within the Manhattan Active® Suite over the past year. “Google Cloud’s Partner Awards recognize partners who have created outsized value for customers through the delivery of innovative solutions and a high level of expertise,” said Kevin Ichhpurani, President, Global Partner Ecosystem, Google Cloud. "We're proud to announce Manhattan Associates as a 2025 Google Cloud Partner Award winner and celebrate their impact enabling customer success over the past year." “We are honored to be recognized as Google Cloud’s 2025 Business Applications Partner of the Year Award for Supply Chain and Logistics,”
Debiopharm and Oncodesign Services Launch Strategic Collaboration to Propel Radiopharmaceuticals in Preclinical Research24.4.2025 10:00:00 EEST | Press release
Debiopharm Research & Manufacturing S.A. (Debiopharm, www.debiopharm.com), a Swiss-based global biopharmaceutical company aiming to cure cancer and infectious diseases, and Oncodesign Services (www.oncodesign-services.com), a leading CRO specialized in drug discovery and preclinical services, announce the execution of a license agreement for the use of the AbYlink™ technology for preclinical services. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250424538240/en/ AbYlink™ is a regio-selective bioconjugation technology ideally suited for preparing conjugates for use in therapeutic and non-invasive diagnostic applications. Oncodesign Services will use this cutting-edge technology to prepare antibody chelator conjugates for use in preclinical studies to gain insights into the predictive effectiveness of novel treatment approaches in Molecular Radiotherapy, and particularly Radioimmunotherapy in the context of cancer. A joint p
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom